Recursion Pharmaceuticals, Inc. (RXRX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XMEX $
2. 94
-0.08
-2.4834%
$
1.59B Market Cap
- P/E Ratio
- Div Yield
19.28M Volume
-1.72 Eps
$ 3.02
Previous Close 
Want to track RXRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Recursion Pharmaceuticals, Inc. (RXRX) Statistics
Valuation metrics
Market Cap 1.59B
Enterprise value 734.88M
Trailing P/E (ttm) -2.45
Forward P/E -
PEG ratio -0.07
Price/Sales (ttm) 19.87
Price/Book (mrq) 1.52
Enterprise Value/Revenue 11.09
Enterprise Value/EBITDA -1.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 24.56M
Average volume (90 days) 18.1M
Price summary
52-Week low 2.77
52-Week high 7.18
Beta -
50-Day moving average 3.38
200-Day moving average 3.61
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -8.44%
Operating margin -8.83%
Operational effectiveness
Return on assets -0.42%
Return on equity -0.54%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.13
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.06
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.24
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 5.47%
Book value per share (mrq) 1.94
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
